Search results for CD103 Antibody

Anti-CD103 antibody [EPR4166(2)], Abcam, AB129202

What is this antibody validated in? Anti-CD103 antibody [EPR4166(2)] (ab129202) is a rabbit recombinant monoclonal antibody and is validated for use in Immunohistochemistry (IHC-P) in Human samples. Trusted by the scientific community Anti-CD103 [EPR4166(2)] (ab129202) was first used in a scientific publication in 2012 and has been cited over 40 times in peer-reviewed journals. Reviewed by scientists Anti-CD103 [EPR4166(2)] (ab129202) has over 5 independent reviews from customers. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies. Other related products We have a range of other formats of antibody clone [EPR4166(2)] also available for your convenience: ab129202, Carrier free - ab221210 , Alexa Fluor® 647 - ab225153 , Carrier free - ab271889 , Alexa Fluor® 488 - ab311021 , Alexa Fluor® 568 - ab313073 , Alexa Fluor® 555 - ab313269 , Alexa Fluor® 750 - ab321038 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-CD103 antibody [ITGAE/2063], Abcam, AB238010

Anti-CD103 antibody [ITGAE/2474], Abcam, AB238011

PE Anti-CD103 antibody [OX62], Abcam, AB95763

PE Anti-CD103 antibody [SP301], Abcam, AB306484

This conjugated primary antibody is "made to order" and it is released using a quantitative quality control method that ensures binding affinity and labelling efficiency of the conjugate. Via leveraging the power of the Lightning-Link ® conjugation technology , Abcam will deliver highly consistent recombinant conjugates in <2 weeks, giving you access to an ever growing portfolio of antibody-label combinations. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. How are conjugated primary antibodies validated? This conjugated primary antibody is released using a quantitative quality control method that evaluates binding affinity post-conjugation and efficiency of antibody labeling. For suitable applications and species reactivity, please refer to the unconjugated version of this clone. Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

CD103 Antibody (YA1243)(PBS only), MedChemexpress, HY-P81498A

CD103 Antibody (YA1243) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to CD103.

CD103 Antibody (PE / Cyanine 5.5), Abbexa, abx228785

CD103 antibody (PE / Cyanine 5.5) is a Rat monoclonal antibody against CD103.

CD103 antibody (Ber-ACT8) [APC], Covalab, Ref 00114343

CD103 antibody (Ber-ACT8) [FITC], Covalab, Ref 00114344

CD103 antibody (Ber-ACT8) [PE], Covalab, Ref 00114345